When clinical characteristics and biochemical variables were compared between the two identified groups, it was found that the patients with MASH had significantly higher values of ALT, AST, LDL-C, fasting insulin, and HOMA-IR (p < 0.05) than the Not-MASH subgroup (Table S5). Here, GPT is linked to metabolic dysfunction-associated steatohepatitis.